-
The State Drug Administration issued an announcement on the implementation of the "Regulations on the Supervision and Administration of Medical Devices" and other matters
Time of Update: 2021-07-31
2. Regarding medical device registration and filing management Starting from June 1, 2021, before the relevant provisions of the new "Regulations" supporting registration and filing are issued and implemented, medical device registration applicants and filing persons will continue to apply for registration and filing in accordance with the current regulations .
-
The second domestic company, Chenxin Pharmaceutical's Teriflunomide Generic Drug Application for Production
Time of Update: 2021-07-31
In China, teriflunomide in July 2018 was NMPA approved for the treatment of relapsing forms of MS, the trade name Obama Czech Republic, has become the first approved oral DMT-listed drugs .
-
WHO says the epidemic may not be fully controlled this year
Time of Update: 2021-07-31
Comprehensive news: The latest data from the official website of the World Health Organization shows that as of 17:42 on the 19th Central European Time, there are a total of 190,597,409 confirmed cases of new crowns worldwide, and a total of 4093145 deaths .
-
National Medical Insurance Administration: Several measures are being formulated to accelerate the implementation of the "Internet +" medical insurance payment policy
Time of Update: 2021-07-31
A few days ago, the National Medical Insurance Bureau emphasized in its response to Recommendation No. 6235 of the Fourth Session of the 13th National People’s Congress that it is formulating a "Int
-
From Fang Niu Baby to Harvard Ph.D. Returned Scholars Talking About Tibetan Medicine Going Global
Time of Update: 2021-07-31
: Tibetan returned scholars talk about how Tibetan medicine can go to the world China News Agency reporter Ran Wenjuan Nineteen years ago, Yangga became one of the first batch of postgraduates in Tibetan medicine since the establishment of the Tibet Autonomous Region .
-
Research shows that the new crown antibody can be retained for at least 9 months
Time of Update: 2021-07-31
In February and March 2020, 85% of the 3000 residents of the village of Vau in northern Italy were tested for the new crown virus .
8% of people infected with the new coronavirus in February and March were still able to detect antibodies by November .
-
China Food and Drug Administration: Soliciting opinions on medical device registration self-inspection work regulations
Time of Update: 2021-07-31
Medical Network, July 26, July 23, in order to do a good job in the preparation and revision of the supporting documents of the Regulations on the Supervision and Administration of Medical Devices, t
-
Children with diabetes usher in the first weekly GLP-1 receptor agonist therapy
Time of Update: 2021-07-31
Reference materials:[1] BYDUREON BCise (exenatide extended-release) Approved in the US for the Treatment of Type 2 Diabetes in Pediatric Patients Ages 10 Years and Older.
Retrieved July 23, 2021, from https:// home/20210723005083/en/BYDUREON-BCise-exenatide-extended-release-Approved-in-the-US-for-the-Treatment-of-Type-2-Diabetes-in-Pediatric-Patients-Ages-10-Years- and-Older
-
emegency notice!
Time of Update: 2021-07-31
The provincial procurement platform requires pharmaceutical companies to upload the "Credit Commitment" in a timely manner, which is the follow-up designated action of the implementation plan of the "National Medical Security Administration's Guiding Opinions on Establishing a Pharmaceutical Price and Recruitment Credit Evaluation System" (hereinafter referred to as the "Guiding Opinions") .
-
The integration of processing of Chinese medicinal materials and production of decoction pieces has advantages
Time of Update: 2021-07-31
Regarding the integration of origin processing and decoction pieces production, the author proposes to build a batch of single-variety decoction pieces factories and regional decoction pieces factories in the main producing areas of authentic medicinal materials, and concentrate and divert flows through the storage and logistics base of Chinese medicinal materials to achieve "Internet +" unified national distribution Directly with one station .
-
Defeat drug resistance and eradicate cancer cells!
Time of Update: 2021-07-31
Subsequently, the researchers conducted in vivo experiments on ErSO in several preclinical orthotopic and metastatic mouse models that carry xenografts of different human breast cancer cell lines or patient-derived breast tumors .
-
Researchers reveal the relationship between inflammation and tumor occurrence, development and treatment
Time of Update: 2021-07-31
In acute inflammation, most inflammatory cells can kill pathogens, promote tissue repair, prevent tumor growth, and then play a role in suppressing cancer; once the inflammation does not subside in time, it will turn into chronic inflammation, which may induce a number of malignant tumors.
-
Symposium on Innovation and Development of Medical Devices Held in Beijing
Time of Update: 2021-07-31
Medicines Medicines Medicines Medical Devices Medical Devices Medical Devices Xu Jinghe emphasized that the joint efforts of the industry and the regulatory authorities are needed to realize the transformation of China from a big country in the manufacture of machinery to a strong country in the manufacture of machinery and to better protect the public's demand for machinery .
-
The State Food and Drug Administration requests revision of propranolol tablet instructions
Time of Update: 2021-07-31
" For propranolol tablets that have not passed the consistency evaluation, the following content should be added in the item of "Precautions": "Children should use this product with caution, and there are the following tips on children's medication in similar foreign drug inserts" .
-
The State Food and Drug Administration issued the "Announcement on the Registration Items of the Master File of Medical Devices" on the 12th
Time of Update: 2021-07-31
After the materials are successfully submitted, the Approval Center will send the medical device master file registration receipt (Annex 3) to the owner of the master file or its agency .
-
The State Drug Administration issued a notice on the issuance of the "Administrative Measures for Drug Inspection (Trial)"
Time of Update: 2021-07-31
On May 28, in order to implement the "Drug Administration Law" and the "Vaccine Administration Law", further standardize drug inspection behavior, and promote drug supervision work to adapt to the n
-
Priority purchase and use of selected products!
Time of Update: 2021-07-31
picture The third is to explore the implementation of medical insurance payment standards In terms of medical insurance payment, the "Notice" mentioned the expenses incurred by Shanghai insured persons using the selected coronary balloon dilatation catheters or coronary balloon drug-coated catheters, and canceled the original proportionate self-pay part, and fully included in the medical insurance payment scope , Pay directly according to the basic medical insurance regulations .
-
Yiling Pharmaceutical Ranks Seventh in the TOP100 Ranking of Chinese Medicine Companies
Time of Update: 2021-07-31
Schematic diagram of Yiling Pharmaceutical's 2016-2020 operating income growth Under the leadership of the series of major innovations in TCM collateral disease theory, Yiling Pharmaceutical has won the National Science and Technology Award six times .
-
Avantor® acquires RIM Bio and expands the production of biological products to China
Time of Update: 2021-07-31
Avantor (NYSE: AVTR), a provider of key products and services to industries such as life sciences, advanced technology and applied materials, announced today that it has completed the acquisition of RIM Bio .
-
Pharmacopoeia Commission: 124 drugs and 49 general technical standards improvement tasks are released
Time of Update: 2021-07-31
Please send the electronic version of the contract according to the category to the corresponding office contact email address before March 15, 2021 .